1. Home
  2. ADVM vs SELX Comparison

ADVM vs SELX Comparison

Compare ADVM & SELX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ADVM
  • SELX
  • Stock Information
  • Founded
  • ADVM 2006
  • SELX 2021
  • Country
  • ADVM United States
  • SELX Taiwan
  • Employees
  • ADVM N/A
  • SELX N/A
  • Industry
  • ADVM Biotechnology: Biological Products (No Diagnostic Substances)
  • SELX
  • Sector
  • ADVM Health Care
  • SELX
  • Exchange
  • ADVM Nasdaq
  • SELX Nasdaq
  • Market Cap
  • ADVM 59.5M
  • SELX 59.1M
  • IPO Year
  • ADVM 2014
  • SELX N/A
  • Fundamental
  • Price
  • ADVM $2.81
  • SELX $1.55
  • Analyst Decision
  • ADVM Strong Buy
  • SELX
  • Analyst Count
  • ADVM 5
  • SELX 0
  • Target Price
  • ADVM $26.60
  • SELX N/A
  • AVG Volume (30 Days)
  • ADVM 517.4K
  • SELX 7.8K
  • Earning Date
  • ADVM 05-20-2025
  • SELX 01-01-0001
  • Dividend Yield
  • ADVM N/A
  • SELX N/A
  • EPS Growth
  • ADVM N/A
  • SELX N/A
  • EPS
  • ADVM N/A
  • SELX N/A
  • Revenue
  • ADVM $1,000,000.00
  • SELX $1,040,571.00
  • Revenue This Year
  • ADVM N/A
  • SELX N/A
  • Revenue Next Year
  • ADVM $42.58
  • SELX N/A
  • P/E Ratio
  • ADVM N/A
  • SELX N/A
  • Revenue Growth
  • ADVM N/A
  • SELX N/A
  • 52 Week Low
  • ADVM $2.64
  • SELX $1.00
  • 52 Week High
  • ADVM $10.84
  • SELX $2.63
  • Technical
  • Relative Strength Index (RSI)
  • ADVM 38.23
  • SELX 53.96
  • Support Level
  • ADVM $2.64
  • SELX $1.50
  • Resistance Level
  • ADVM $3.64
  • SELX $1.78
  • Average True Range (ATR)
  • ADVM 0.32
  • SELX 0.20
  • MACD
  • ADVM 0.04
  • SELX 0.00
  • Stochastic Oscillator
  • ADVM 17.00
  • SELX 47.06

About ADVM Adverum Biotechnologies Inc.

Adverum Biotechnologies Inc is a clinical-stage company that aims to establish gene therapy as a new standard of care for prevalent ocular diseases. It develops gene therapy product candidates intended to provide durable efficacy by inducing sustained expression of a therapeutic protein. Its product candidate, ixoberogene soroparvovec (Ixo-vec), is a single, in-office intravitreal (IVT) injection gene therapy product designed to deliver long-term durable therapeutic levels of aflibercept associated with a robust, sustained treatment response, reducing the treatment burden and fluctuations in macular fluid associated with bolus anti-vascular endothelial growth factor (VEGF) IVT injections.

About SELX Semilux International Ltd. Ordinary Shares

Semilux International Ltd is a company that operates through its subsidiaries which is an optical and 3D sensing technology company that is involved in the customization, design and supply of optical components and integrated chip for various industries including autonomous driving, intelligent lighting, as well as unmanned aerial vehicles. In collaboration with its clients, TCO conceptualizes and produces high precision optics and sensing modules that are specifically customized to clients' needs for ease of integration in overall design and production. Applications for TCO's products include automotive laser headlight systems, adaptive driving beams (ADB) as well as light detection and autonomous driving systems (LiDAR).

Share on Social Networks: